deVere White R, Deitch A D, Hong W K, Olsson C A
Urol Res. 1985;13(1):35-8. doi: 10.1007/BF00571754.
The potential ability of cytoreductive surgery to increase the effectiveness of chemotherapy (vindesine) was tested utilizing male Wistar Lewis rats transplanted simultaneously with intraperitoneal and flank implants of a spontaneously arising renal adenocarcinoma. Cytoreduction was accomplished in some animals by removing the flank tumor 5-7 weeks following implantation; all animals received vindesine (IP injection of 0.5 mg/kg on two successive weeks). While vindesine reduced tumor growth, in no case did the addition of cytoreductive surgery enhance the effect of chemotherapy. The addition of cytoreductive surgery to marginally effective chemotherapy was found to be ineffective or even detrimental.
利用雄性Wistar Lewis大鼠,通过同时在其腹腔内和胁腹植入自发产生的肾腺癌,来测试减瘤手术提高化疗(长春地辛)效果的潜在能力。在植入后5 - 7周,通过切除部分动物的胁腹肿瘤来实现减瘤;所有动物均接受长春地辛治疗(连续两周腹腔注射0.5 mg/kg)。虽然长春地辛可减缓肿瘤生长,但在任何情况下,减瘤手术的加入均未增强化疗效果。结果发现,在疗效欠佳的化疗基础上增加减瘤手术无效甚至有害。